Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation
about
Identification of both positive and negative domains within the epidermal growth factor receptor COOH-terminal region for signal transducer and activator of transcription (STAT) activationAnkyrin repeat and SOCS box 3 (ASB3) mediates ubiquitination and degradation of tumor necrosis factor receptor IICentral role of the threonine residue within the p+1 loop of receptor tyrosine kinase in STAT3 constitutive phosphorylation in metastatic cancer cellsMechanisms of Interferon-alpha induced apoptosis in malignant cellsAntibodies immobilized as arrays to profile protein post-translational modifications in mammalian cellsRole of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cellsPhospho-SXXE/D motif mediated TNF receptor 1-TRADD death domain complex formation for T cell activation and migration.Information theoretic approach to complex biological network reconstruction: application to cytokine release in RAW 264.7 macrophagesTargeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibitionSTAT1 regulates the homeostatic component of visual cortical plasticity via an AMPA receptor-mediated mechanismA single dose of carbon monoxide intraperitoneal administration protects rat intestine from injury induced by lipopolysaccharideThe clinical and biological significance of STAT1 in esophageal squamous cell carcinoma.Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome.Suppression of interferon lambda signaling by SOCS-1 results in their excessive production during influenza virus infectionTranscriptional regulation via TF-modifying enzymes: an integrative model-based analysis.NF-kappaB protects cells from gamma interferon-induced RIP1-dependent necroptosis.Mangiferin has an additive effect on the apoptotic properties of hesperidin in Cyclopia sp. tea extracts.Neurodegenerative and inflammatory pathway components linked to TNF-α/TNFR1 signaling in the glaucomatous human retina.Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel diseasePretreatment with Fucoidan from Fucus vesiculosus Protected against ConA-Induced Acute Liver Injury by Inhibiting Both Intrinsic and Extrinsic ApoptosisAn astrocyte-specific proteomic approach to inflammatory responses in experimental rat glaucomaThe promise of cytokine antibody arrays in the drug discovery process.Protein microarrays as a discovery tool for studying protein-protein interactions.Opposing actions of STAT-1 and STAT-3.Airway smooth muscle cell as an inflammatory cell: lessons learned from interferon signaling pathwaysTumor necrosis factor-alpha is produced by dying retinal neurons and is required for Muller glia proliferation during zebrafish retinal regeneration.Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B.Evidence that genetic deletion of the TNF receptor p60 or p80 inhibits Fas mediated apoptosis in macrophages.Transcriptional regulation of cytokine function in airway smooth muscle cells.Highly frequent anti-idiotype antibody in cynomolgus monkeys developed against mouse-derived regions of anti-Fas antibody humanized by complementarity determining region grafting.STAT2 and IRF9: Beyond ISGF3.Acetylation of Stat1 modulates NF-kappaB activityInhibition of tumor necrosis factor alpha-mediated NFkappaB activation and leukocyte adhesion, with enhanced endothelial apoptosis, by G protein-linked receptor (TP) ligands.STAT1 mediates transmembrane TNF-alpha-induced formation of death-inducing signaling complex and apoptotic signaling via TNFR1.TNF- α and IFN-s-dependent muscle decay is linked to NF-κB- and STAT-1α-stimulated Atrogin1 and MuRF1 genes in C2C12 myotubes.IFN-gamma does not mimic the catabolic effects of TNF-alpha.Lack of requirement of STAT1 for activation of nuclear factor-kappaB, c-Jun NH2-terminal protein kinase, and apoptosis by tumor necrosis factor-alpha.Cytokine inhibition of fibroblast-induced gel contraction is mediated by PGE(2) and NO acting through separate parallel pathways.Innate immunity in pluripotent human cells: attenuated response to interferon-β.AhR-deficiency as a cause of demyelinating disease and inflammation.
P2860
Q24299920-D0A68403-97FE-48E5-89CB-B4851BAEA822Q24529081-C116ED88-8D40-4073-B25B-EA71E002196FQ24563513-9CCCEF8F-7D85-4320-9A73-5FC85863D5BAQ28202091-B9044AA4-688E-4AD6-8CD3-A58196F32DA5Q28259973-FBC8334C-4486-4FB9-A440-2E0B9B909D35Q28570142-916EE450-0C92-447C-A7A2-DB73652614FBQ30502703-8BBB2B8F-BA65-4401-BFF3-71D6B74522EDQ33891673-B4D7A08D-DA6B-40A1-B52D-96C3566A2EB9Q33917016-28367CEE-990B-41BD-A2B9-43F78D8D321FQ33969810-D9F5723C-842C-4D3C-B400-C40A4483137AQ34427499-ECDA0641-B608-496C-AAF9-D05F327613CDQ34517533-3B2019BB-5C43-4D47-BFC9-68A33E3EB6C4Q34669630-A8F9472A-0B5C-4B1F-BFC4-FB425D9B2496Q35082203-04CFC223-A619-48A5-A885-2C302DFD3F18Q35088085-B89FEA86-920C-4566-A798-5B2B675C3799Q35096633-CF6C4509-FEE5-4F71-9CBE-32AE0B383CF7Q35122053-6765439F-8FFD-4291-B944-B170D8E4C3F9Q35524470-57BF691A-9B2A-4BBF-88C1-56FF958C7549Q35594920-B8A6307D-2844-4325-871D-6BC37E4AD60AQ35976307-300BF4B6-075F-4AC4-81DF-CFC73620B4CDQ36082780-8CA6E5E4-3EBE-4BA8-9D76-0C3A0C4E96B9Q36158736-7FFEF516-9042-4DBA-A64A-9CD8EB690345Q36168440-5D870449-B3EF-482A-8111-7D48311FA305Q36294468-C250EE89-A2FD-4DA7-818C-2FE80F4FDDE9Q37038081-4EDA0B13-6102-425C-A935-4387A6809F3DQ37087874-29D30432-06B9-4A6E-9245-ED52AF50925FQ37108918-C6A83351-D719-4FB1-8556-48B88FA3A3C1Q37243284-2F2E3A12-7DBB-4307-A170-BA0CA59ED788Q37329286-AA75F195-0A14-4AE8-A2C0-ABB599BA0B0DQ37376969-BA4E7750-345A-423E-AA1B-4E7721BB85EAQ38185399-57F3BAEC-B579-47E3-83CB-3750C4B7C7AFQ38315771-F1F80A07-FCCF-421C-8785-E14B24E7166BQ38358934-8898DBEE-BD09-40E1-A625-44139D004D88Q38716952-4F4EB406-4FF2-47FF-B5A2-14C750DF4BBDQ39031553-B0DEDA68-E040-4CAF-8683-A09A2E303C25Q40069451-3F6DDF5F-309B-4D58-B26E-8DC774A48D48Q40752073-91EA1818-253C-4B0F-8BEC-ADE829857E53Q40785625-10886F2A-C234-4D4B-8AEC-864B175540CBQ41282268-A9523A04-1B56-45D5-A95C-94020D38E70BQ41548297-D8B437BF-8C6B-452A-ADCF-F8010DC503E1
P2860
Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-kappaB activation
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Stat1 as a component of tumor ...... o inhibit NF-kappaB activation
@ast
Stat1 as a component of tumor ...... o inhibit NF-kappaB activation
@en
Stat1 as a component of tumor ...... o inhibit NF-kappaB activation
@en-gb
Stat1 as a component of tumor ...... o inhibit NF-kappaB activation
@nl
type
label
Stat1 as a component of tumor ...... o inhibit NF-kappaB activation
@ast
Stat1 as a component of tumor ...... o inhibit NF-kappaB activation
@en
Stat1 as a component of tumor ...... o inhibit NF-kappaB activation
@en-gb
Stat1 as a component of tumor ...... o inhibit NF-kappaB activation
@nl
prefLabel
Stat1 as a component of tumor ...... o inhibit NF-kappaB activation
@ast
Stat1 as a component of tumor ...... o inhibit NF-kappaB activation
@en
Stat1 as a component of tumor ...... o inhibit NF-kappaB activation
@en-gb
Stat1 as a component of tumor ...... o inhibit NF-kappaB activation
@nl
P2093
P2860
P921
P3181
P1476
Stat1 as a component of tumor ...... o inhibit NF-kappaB activation
@en
P2093
P2860
P304
P3181
P356
10.1128/MCB.20.13.4505-4512.2000
P407
P577
2000-07-01T00:00:00Z